In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Debating Small Differences

Executive Summary

The European Court of Justice has been wrestling with a set of sticky questions: to what extent should the existence of a new version of a drug influence what becomes of a previous version? The case that is raising these issues was filed by Rhone-Poulenc Rorer in June 1997, as a protest against a decision by the UK Medicines Control Agency, which granted a parallel import license for an old version of RPR's insomnia treatment zopiclone.

You may also be interested in...



Dutch Regulator Backs Paracetamol Safety After Possible Carcinogen Detected

Netherlands' Medicines Evaluation Board says the safety of paracetamol is "not up for debate" after a media investigation reported contamination of the drug with a possible human carcinogen. 

Allergan Declines To Confirm Abicipar Pegol Fate

There is speculation that it is the end of the road for abicipar pegol but Allergan has declined to say whether this is the case for the product that has been in development for wet AMD.

EU Industry Wants IVDR Delay, Grace Period For More Products And Phased Implementation

In the EU, voices calling for a postponement of the IVD Regulation’s 2022 enforcement date are growing louder.

Topics

UsernamePublicRestriction

Register

LL1132999

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel